Monday, February 15, 2010

The Best Investment Books

Follow on Twitter


February 15, 2010

There are literally thousands of investment books out there. The books listed below have been written by the most experienced investors. They are the best of the best that we have found so far. There will be more to come as we continue to review, but we will only recommend those in which we think will help the investor get the education needed to invest wisely and make intelligent investing decisions. The top 3 are my favorites. More to come on charts and other stock picking techniques.

If you were to read all of the below books you would not only have a great knowledge of how to evaluate and pick stocks for yourself but a good education on how the economy works. There is literally a WEALTH of knowledge in these books that each and every investor will benefit greatly from. These are the best of the best. These books contain information that should significantly increase your investing knowledge as professional wall street investors use them, and they are not too difficult to read or understand.


The Intelligent Investor by Benjamin Graham.

If you want to invest the good ole fashioned way then this is definitely for you. This is perhaps the most important and influential book ever written about value investing. Originally published in 1934 by Ben Graham, this work has been heralded by such notable investors as Warren Buffett as "the best investing book ever written". In it, Graham presents two types of investing styles - one for every day people who don't want to think about their portfolios ("defensive") and the business man or woman who wants to enjoy maximum returns ("enterprising").
The Intelligent Investor







One Up On WallStreet by Peter Lynch and John Rothchild

One up on Wall Street is one of the first books any investor should read. In it, famed mutual fund manager Peter Lynch teaches you how to use what you already know to make money in the market. You will get a lot of Bang for your Buck. One of the most highly reviewed investment books. You may have to dust off most of your books in your library, but not this one as you will come to it time after time. Every investor should read this one! We often strive to find the great stock, when the great stock was striving to find us! Peter Lynch.


One Up On WallStreet








The Essays of Warren Buffett: by Warren E. Buffett and Lawrence A. Cunningham

I personally live in Nebraska and we ALL know Warren Buffet and we desire to invest the Warren Buffet way. Anyone who is worth their salt as an investor has read the Berkshire Hathaway shareholder letters, written by Buffett. In this book, Professor Lawrence Cunningham selects and arranges these corporate "essays" by topic and relevance. It is a great tool to have handy and can teach you a lot about management, business valuation, investing philosophy, the use of stock options, economic and accounting goodwill and more.
The definitive work concerning Warren Buffett and intelligent investment philosophy, this is a collection of Buffett's letters to the shareholders of Berkshire Hathaway written over the past few decades that together furnish an enormously valuable informal education. The letters distill in plain words all the basic principles of sound business practices. They are arranged and introduced by a leading apostle of the 'value' school and noted scholar, Lawrence Cunningham.

What's new in the second edition? This new edition has extensive additional content that highlights topics of vital national or international significance, including:
- the proliferation of stock option compensation and excessive CEO pay;
- Berkshire s shareholder-designated contribution program and the controversy over the abortion issue that led to its termination;
- the explosion of derivative financial instruments and related perils and how Berkshire dealt with managing a sizable portfolio of them after buying Gen Re;
- the dramatic increase in foreign currency trading in the past five years along with the astonishing growth in the US trade deficit;
- management succession at Berkshire Hathaway as Mr. Buffett ages;
- commentary on his philanthropic thinking in giving his entire fortune to charities; and
- the fairness and other matters concerning taxation of corporations.

Here in one place are the priceless pearls of business and investment wisdom, woven into a delightful narrative on the major topics concerning both managers and investors. These timeless lessons are useful to members of a wide range of professions, including law, accounting, finance and management, and provide rich teaching materials for courses in those fields.

The Essays of Warren Buffett






Common Stocks and Uncommon Profits & Other Writings: by Philip A. Fisher and Ken Fisher

Philip Fisher is one of the most prominent and important financial thinkers in history. One of the most beloved investment books of all time. In this book, he examines the fifteen qualities of an excellent business. When this approach is coupled with Graham's "value" method, it can be a very powerful thing. Here is what Warren Buffet says: "I sought out Phil Fisher after reading his Common Stocks and Uncommon Profits and Other Writings. When I met him, I was as impressed by the man as by his ideas. A thorough understanding of the business, obtained by using Phil’s techniques . . . enables one to make intelligent investment commitments."
–– Warren Buffett
Common Stocks and Uncommon Profits & Other Writings




Go to the bottom of this page and look for the “Bundle” Deals.





Security Analysis 6th Edition: Sixth Edition, Foreword by Warren Buffett (Limited Leatherbound Edition) (Security Analysis Prior Editions) by Benjamin Graham and David Dodd (Hardcover - Sept. 19, 2008) Warren Buffett developed some of his trading styles from this legendary author---The Father of Investment Books author----Benjamin Graham.

The Grand Father of all trading books. Warren Buffet has written this updated version's foreword because Warren has used some of these methods to analyze, value and choose stocks for years now. Security Analyis was originally written by Professor Benjamin Graham in 1934. Five editions and a million copies later, the seven hundred page investing treatise will teach you how to analyze and value almost any investment. If you take more than a casual interest in building your networth, this book will change your life.



OR Hard Copy cheaper! Security Analysis 6th Edition Hard Copy


Security Analysis 6th Edition Leather Back





Investopedia to Wall Speak

This book "Investopedia to Wall Speak" is a **MUST HAVE for all traders; especially Beginners. Why? Because it explains the terminology of the stock world. The 10K, 10k, 8k, just everything regarding investment terms that you WILL run across and ask yourself "what does this mean". This will be your quick reference book that you will turn to to all the time. Well worth it. This book is the glossory of all stock terms that is very easy to read and well explained. If you are going to trade stocks and be serious about trading this book will help you big time. Spend the $12.89 because it is well worth it. You will learn sooo much and you will not be in the dark when reading those financial statements. This is a great book to go with the others because you will easily understand the terms in the other books.










Security Analysis on Wall Street: A Comprehensive Guide to Today's Valuation Methods, Univ. Edition (Wiley Frontiers in Finance) by Jeffrey C. Hooke (Paperback - Sept. 3, 1999)

This book focuses on helping the average investor make a value investment on a specified type of stock. It will show many examples. You will learn that many firms exaggerate their sales to dupe you, the investor into either not selling or buying. After reading this you should be confident in making a secure investment, an investment that you can go to bed and sleep soundly because you know you have invested in a growing company. The author Jeff Hooke worked on Wall Street. This book will give you many real examples and charts. It is a MUST Read for those who do their own research and do not have a broker.

Security Analysis on Wall Street: A Comprehensive Guide to Today's Valuation Methods








The Interpretation of Financial Statements (Hardcover) by Benjamin Graham, Spencer B. Meredith and Michael F. Price.

Financial Statements usually give an accurate picture of a company. If you are investing on your own without a broker you are in fact your own broker; so you have to know what a broker knows. This book is a good way of self-educating. If you invest in penny stocks you absolutely must know how to read these statements because most penny stocks don't make it. Become an intelligent investor leader, not a loser follower. Know the financial terms and expressions as they often can be tricky to comprehend to the average investor. A book for that one and ALL investors should read.

The Interpretation of Financial Statements






The 9 Steps to Financial Freedom: Practical and Spiritual Steps So You Can Stop Worrying (Paperback) by Suze Orman

The Money Management Queen tells all in this great seller. Here are the 9 steps to financial freedom: 1. Step back in time to see how your feelings about money can be traced to your past. We all have "money messages" passed down from generation to generation. 2. Face your money fears and create new, positive truths. 3. Be honest with yourself. Ouit using plastic cards for money. They are addictive and destructive as drugs, giving you a quick fix by satisfying temporary desires. 4. Be responsible to those you love. Establish life insurance, wills, power of attorney, estate planning, etc. 5. Be respectful of yourself and your money. If you do what needs to be done with money, you will attract money to you. 6. You and your money must keep good company. Credit cards are never good company. Get out of debt. Respect yourself and your money by making every penny work for you. 7. Trust yourself more than you trust others. Find the "little voice" inside you; listen to what it has to say. 8. Be open to receive all you are meant to receive. When you are in control of your money and have enough to be generous, money flows to you. 9. Understand the ebb and flow of the money cycle. Money has natural cycles as it ebbs and flows through your life. Remember this: There are three ways of getting money in this world: (1) Work for it (2) inherit it (3) invest the money you save (the most powerful, respectful way to get money there is). You cannot be successful until you lose your fear of money. This is a good read and a very popular book that teaches you all about managing money.

The 9 Steps to Financial Freedom







The New Buffetology: The Proven Techniques for Investing Successfully in Changing Markets That Have Made Warren Buffett the World's Most Famous Investor (Hardcover) by Mary Buffet and David Clark.

This book doesn’t just talk about financial analysis, it shows you directly how to do it yourself. This describes the Warren Buffet style of investing and how he came to make a decision on buying a company with a Durable Competitive Advantage; the phrase used most. It explains some of Warren’t thinking when he bought Coke, Geico, etc. If you believe in value investing this book should be worth your while. It is simple to read and you can practice what you learn by browsing over some balance sheets on Yahoo Finance. There is one thing about Warren and that is he can almost see the future. He doesn’t use a chart to invest, he doesn’t invest in the “hot” stocks of today, he doesn’t go with momentum, he rather looks at a company that is undervalued in which he believes will be discovered and take off someday. His track record is truly amazing; no one on Earth can deny this. If you want to how the Greatest Investor to ever live makes a decision, then this is probably for you.
The New Buffetology






Warren Buffet and the Interpretation of Financial Statements: The Searh for a Company with a Durable Competitive Advantage: The Search for the Company with a Durable Competitive Advantage [Deckle Edge] (Hardcover) by Mary Buffet and David Clark.

This is another book that helps interpret financial statements. This book is easy to read and I would say that it is for beginners. I would recommend reading “The Interpretation of Financial Statements” after this one if you have not read that one first. If you have a basic knowledge of finance and accounting you many not necessarily need this one, but is good for beginners. *Note: Mary Buffet was married to Warren’s son for 12 years. A book that most Professional Financial Institutional Investors have by their sides is “New Buffettology”, a great read for anyone who is Serious about investing. See above.
Warren Buffet and the Interpretation of Financial Statements: The Searh for a Company with a Durable Competitive Advantage







How to Detect Financial Shenanigans
Financial Shenanigans: How to Detect Accounting Gimmicks and Fraud by Howard Schilit (Hardcover - Mar. 1, 2002).

This book is actually not that difficult to read considering it is dealing with accounting. It is a great book for anyone doing their own investing (especially short investing). It is a good book to add to your financial education. Not the first book I would read, but I would recommend to add to the realm of your investment knowledge because sooner or later you will run into a company that is inflating it’s numbers and by reading this book you should know how to spot that it. For such a small price you can save some big bucks.

How to Detect Financial Shenanigans








Is your computer running slower and slower? Have computer Errors popped up on your screen? Does your computer every freeze up?? Have you thought about re-installing Windows?
Don’t do it: There is an easy fix that is recommended and most widely used by the EXPERTS. Why pay someone to do this?
Click Here!



Download entire Movies to your computer. 100% Legal. No worry about viruses or spy ware. Works with small bandwidth, so anyone can do this. This is not a file sharing P2p deal here; this is Direct downloads to your computer. Create your DVD collection on your computer.
Click Here!



Use what the Private Investigators Use. Find almost ANYTHING you want to find out about ANYBODY.

Search for ALL Public Records on Sex Offenders in your neighborhood, search Civil Records, search Businesses, CEO’s and Bankruptcies. Look up old Marriage Records, look up Death Records, and get UNLIMITED Public Record Checks. Find Anyone, Anywhere! Get their current phone number and phone number history, current and previous addresses. Use what Private Investigators use.
Get Started Now!

Friday, February 12, 2010

Why has LUXD gone up over 100% in a week?

Follow me on Twitter


February 15, 2010

A Heads up for LUXD traders.

In order to fund the further development of its Assets the Company intends to attempt to raise additional Equity through the sale of common shares of its stock in the next year.
There are 2,500,000 shares of preferred stock that will be convertible to common shares, at the holder's election, at a rate of 10 common shares for each preferred share. The holder in this case is LUXD’s founders as stated in 10Q. This will be another 25 Million shares introduced to the total outstanding shares. Since LUXD stated that they are planning on selling shares to raise additional capital, I would surmise that once these preferred shares are converted to common’s that the selling will begin. The contract for these preferred were for 2 years and they issued in the period ending August 2008, so they could begin selling these shares in may if that is in fact when they issued them.

As you all probably know that LUXD has been heavily promoted the past couple of weeks. From February 3rd, 2010 stock price of .05 to February 11, 2010 stock price of .12. That is a good run of over 100% in one weeks worth of trading days. The below email advertisers received 1 million shares each ; yes FREE trading shares for this penny stock, so they can unload these whenever they desire.

Let’s look at the Volume: The average volume of this run up has been about 55,000 in the past 10 days. That is not even 1 million shares; so if just one of these email advertisers chooses to sell their 1 million free trading shares, this could essentially wipe out the 100% plus gain LUXD has experienced.

This is just a precautionary so investors are informed of the truth as I have been ripped off big time from these Free Emailer’s. If you plan on holding Lux Digital Pictures for the long haul you will probably be alright as it appears they will have the funds to make it through 2010. If you are looking to day trade just be aware of this and set your stops accordingly.

There is a total of 18 Million Free Shares that LUXD just gave out to increase their share price. I would imagine that these email advertisers will continue their LUXD advertising campaign for a while, so this is just a heads up, who knows what the stock will do. Here is the full 10Q
I don’t like it when they place the link on Yahoo Financing and they just display the positives of the company; I wish they would display the entire 10Q. This is just a heads up so you don’t get burned as I have on many of these freebie email stock advertising agencies. They are usually the true winners here, because not only do they get FREE shares, but they buy more with their own money just prior to distributing the emails that says how great the company is. Good Luck Trading.
Compensation:
Penny Stock Pipeline - 1,000,000 free trading shares
Below Wall Street - one million free trading shares
Investment Opinions - one million free trading shares
Investment Internet - one million free trading shares
Penny Stock Pipeline - one million free trading shares
Tunnel Stocks - one million free trading shares
Mountain Stocks - one million free trading shares
Lightning Stocks - one million free trading shares
The Future Super Stock - one million free trading shares
Stock Pick Reporter - one million free trading shares
Stocks Commuter - one million free trading shares
The Next Hot Stock - one million free trading shares
The Next Super Stock - one million free trading shares
The Next Stock Winner - one million free trading shares
Wall Street Opinions - one million free trading shares
Emerging Growth - one million free trading shares
QualityStocks.com - one million free trading shares
TheSUBWAY.com - one million free trading shares

That’s a lot of FREE shares people. Wow!

Copybox
Are you LAZY? If you are then this may be for you. All you have to know is how to Copy and Paste which will be described to you step by step. This is a powerful, profitable system that will inform you step by step. If you need some extra $$ to pay the bills then give this a try. A great system for those that are Disabled and need a secondary income or for that matter anyone desiring a second income. Truly no web experience needed as all you need to do is follow the directions step by step. Just check this out.
Click Here!

MovieCap
Download entire Movies to your computer. 100% Legal. No worry about viruses or spy ware. Works with small bandwidth, so anyone can do this. This is not a file sharing P2p deal here; this is Direct downloads to your computer. Create your DVD collection on your computer.
Click Here!

Penny Alerts you cannot Survive without!
Roys Best Penny Alerts. Get in before the Crowds


****JUST ONE LAST NOTE ON LUXD: They only had revenues of a little over $15,000 for the entire quarter! That’s not too great. They had 4 Times this the year before! There is usually a reason why the stock is at a price it is. One Warning sign is also when a company pays to be notices with Free Shares. A big sign that says “Pump and Dump”.

Thursday, February 11, 2010

How to make money from Delcath Systems

Follow me on Twitter


February 12, 2010

How to make $$ on the upcoming Binary Event for Delcath Systems.

On February 9, 2010 Decalth Systems announced that they have began data analysis of their phase III trial (PHP™). If the trial is successful and meets it’s endpoints they believe that they will be on their way to an FDA approval. The data should be analyzed sometime in March with an expected NDA filing for April, 2010.

The CEO of Delcath Systems, Eamonn Hobbs stated that he is very confident that Phase III will meet it’s endpoint. The main objective of Phase III is to improve progression free survival---(Just means you continue to exist without further spreading of cancers) of patients with matastatic melanoma ocular or cutanous to the liver--(this just means the cancer begins in the eye or on the skin and spreads to the liver) treated with the Delcath PHP System VS patients in the control arm. Cancer often begins in the eye (Ocular) or on the skin (Melanoma) and can quickly spread to vital organs, such as the liver and lungs.

The second objective is to demonstrate a statistically significant improvement in the hepatic progression free survival--acronym is (HPFS). This objective in short just says that the Decalth PHP™ System will significantly increase survival rates without further progression of cancer. Evaluation will be based on duration of response and of course the over all survival.

MovieCap
Download entire Movies to your computer. 100% Legal.
Click Here!


What to expect with Delcath’s stock price:


I would surmise that the stock will gradually begin to make an upwards trend for the rest of February into March when Delcath is expected to release results of this binary event.

This is based off of how other Pharmaceutical stocks behave prior to a major binary event. I would expect Delcath, with it’s low float and fairly high institutional ownership to make a run to the $6.00 mark. If the results are meet their endpoints then DCTH should be off to the races.

This is one of the ways that I make quick money in the Biopharm’s. I do a lot of research of upcoming binary events and get in early before the crowds. A recent example is GNVC. They are also expected to come out with results of TNFerade, which I was observing GNVC for about a year now and I bought shares at $1.00 a share as I knew it would at least double, which it. The momentum of this stock was stalled by an IPO offering to raise some cash, but I expect the momentum to continue with GNVC after the dust has settled over that.

Just another example was with VVUS. I knew that they were going to have a binary news event on Qnexa and the news was positive. I bought the stock at $3.89 and sold over $8.00 a share; I am well aware that it went all the way to around $12.50, but the shares I have now are freebies.

This is just one way to make money on biopharm’s. I usually sell half of my shares directly prior to the news release as I usually hold “free shares” by then anyway, due to increase of stock price by 100%. This unquestionably lightens the “worry load” if the news is negative. I have already made my money and am riding the stock with free shares, so the rest is frosting on the cake.

I believe there is some good money to be made from DCTH for the next few weeks, but if you do invest this way---you will have to observe the stock daily to get a good idea to when the news release will occur.


FARMVILLE
This may seem like an animated joke at first, but my friend is using this to make a lot of money right now on Facebook. If you are on Facebook it is a must have. Some of the best strategies on making money from home and a VERY Affordable price.
Click Here!



Phase III summary:
The 92 patient, randomized, multi-center, Phase III study commenced patient enrollment in February 2006. Patients were randomly assigned to receive treatments with ultra-high doses of the chemotherapeutic drug melphalan infused directly into the liver via the Delcath PHP System(TM) or to a control group, where they were provided with best alternative care (BAC). BAC included alternative regional or systemic therapies. Patients assigned to the Delcath arm were eligible to receive up to six cycles of treatment at approximately four to six week intervals. Patients randomized to the non-PHP arm were permitted to cross-over into the Delcath arm at documentation of hepatic disease progression.

The study's primary objective was to demonstrate a statistically significant improvement in the hepatic progression free survival (HPFS) of patients with metastatic melanoma (ocular or cutaneous) to the liver treated with the Delcath PHP System(TM) versus patients in the control arm. Secondary endpoints include response rate, duration of response and overall survival.




About Delcath Systems
Decalth Systems focuses on the development of the Delcath PHP System, (PHP™) a Phase III clinical trial product, which isolates the liver from the patient’s general circulatory system and delivers high dose of melphalan hydrochloride VS Doxorubicin or other therapeutic agents directly to the liver. In short; the Delcath PHP™ System just focuses on the Liver instead as the common chemo agents that run throughout the entire body. When chemotherapy is distributed throughout the entire body it kills and damages many healthy cells. So Delcath wants to isolate the chemo to one organ and at time…in this case, the liver.


Other Trials with Delcath Systems:
Decalth has a collaboration with the National Cancer Institute to develop and evaluate the Delcath System PHP™ device to deliver high-dose melphalan to patients, and to evaluate the use of additional chemotherapy agents with the Delcath PHP System. Delcath Systems, Inc. was founded in 1988 and is based in New York, New York.
This is a positive and a back up plan. The potential is here for DCTH.

The company also conducts Phase II clinical trials to test the Delcath PHP System with the drug melphalan against liver cancer/hepatocellular tumors, neuroendocrine and adenocarcinoma tumors that have spread to the liver, and melanomas metastatic to the liver that have received prior regional treatment.


Note: Delcath’s main competitor right now is Celsion. Celsion is definitely on my watch list as they have a low float and someday the stock will explode. Do your DD and you to stay on the right side of a trade. Their main drug in phase III is Thermodox.

Niche Blueprint 2.0
What if we were to tell you that you could generate more money in just 30 days than most people make in a year, or even a lifetime of blogging, product creation or email promotion combined...anyone who wants to make $$$ from home has to take a good look at this.
Click Here!


Copybox
Are you LAZY? If you are then this may be for you. All you have to know is how to Copy and Paste which will be described to you step by step. This is a powerful, profitable system that will inform you step by step. If you need some extra $$ to pay the bills then give this a try. A great system for those that are disabled and need a secondary income or for that matter anyone desiring a second income. Truly no web experience needed as all you need to do is follow the directions step by step. Just check this out.
Click Here!


****L@@k at this post from Bigfry_52 on Yahoo Finance. A Wall Street Journal Article summarizing Delcath. A terrific find! Click Here.

Recent Posts:
How to make money from Delcath Systems

ART$: You Can’t Judge a Book by its Cover

Is Kraig Biocraft Labs worth investing in?

Trading Penny Stocks Can Change Your Life.



GL Trading!



SEE How a College Dropout Turned $1,000 into $1 Million. Trade Alerts that make you money; Guaranteed! Try it; if you don't like it get your money back, but I have a strong feeling that it could pay for itself within the first couple of trades..even for beginners!
How a College Dropout Turned $1,000 into $1 Million. This can be accomplished with less than 100 Trades. Get his Alerts Now! A Must have for ALL Penny Investors…get on the inside

Tuesday, February 9, 2010

You Can't Judge a Book by its Cover Part II

PART II ARTS: You Can’t Judge a Book by its Cover.

Penny Alerts you cannot Survive without!
Roys Best Penny Alerts. Get in before the Crowds


ART$: You Can’t Judge a Book by its Cover Part I

ART$: You Can’t Judge a Book by its Cover Part II



Forward Looking Statements

Eddie Vakser is legendary for releasing some of the most outrageous, unbelievable, flat out mind blowing press releases. This was the one responsible for the stock going to .045 when The Dean promoted it (There is usually news from the companies that the dean promotes).

Eddie knew that he had to come up with a "Killer Ad", a killer ad that would entice even the extremely vigilant and highly skeptical investors. Eddie Vakser came up with masterpiece. Just as sex sells, so does a brilliant press release that NEVER has a prayer of coming true.

Here it is---released in January 2010: “Artfest projects annual revenues of approximately $60,000,000 to $100,000,000 million by the end of 2010 from its Art Channel Galleries segment, (ACG).”

All I can say is that this was a whopper of a press release that lured in a lot of big fish. Does it have any truth in it? From all the research I have done...in my honest opinion...NONE.



Former Forward Looking Press Releases that have Expired and are No Longer On Yahoo Finance:
Just a couple examples to drive my point.

1. "Artfest International, Inc. Launches Global Social Art Network Rivaling MySpace and YouTube"

Yes, you read correct, it says rivaling Youbube and MySpace. He really must have needed some cash, sent this out to up the price. I have to say this was a Masterpiece also...a work of Art.

2. “Artfest International, Inc. Acquires (State-of-the-Art) Audio/Video Operational Center”

They are always acquiring something “State of the Art” or “Proprietary”, nothing new for Eddie. Yeah, this is working out great right now, LOL. Watch out for trick words like acquire. It makes you think they own something, which they don't! All this means is that they have a room with a video camera...YES that is it. But these misleading press releases are always non-specific, it's just some news to keep the investors content...as he knows he has to keep feeding them hope. Hope is the business model used by Eddie Vakser to keep the investors thinking about how much money they can make if they stick it out and keep putting part of their hard earned pay checks into the company. It doesn't take many people, if you get 1,000 people that put $100 a month, that is an easy $100 K a month put in Eddies cookie jar. He can grab it whenever he wants as he has millions of free shares to trade.



Words of a former employee: supposed to be with CSD section, my mess up.

“I would not trust Eddie with my wallet. Vlad I would not trust with my back! But for some reason, he is out there doing the same thing in the old business. Makes me throw up a little, in my mouth, when I see him at a trade show. Then I feel better knowing I don't work for him anymore!!!”

This is a concern for me as he has a history of mistreating his employees. I think one of the best companies as far as treating their employees with respect, honesty, and pay is Google. Eddie is waaay to cheap to even remotely think about treating his employees 1/8 as good as GOOG.

ArtfestInternational.com Website Visits:

Yo can tell if an online business such as ARTS is working hard by the number of visitors to their website.
If we take a look at the number of people-or-visitors that visit ARTS website, you will find that there is simply not enough visitors to be a successful business, not even close. If any one thing should be an indicator, this should be! Look at all the “Global” statements that Eddie Vakser places in his Press Releases. If what Eddie has been preaching for the past two years is true there should be a minimum of 10,000 unique visitors a day. Think about it. Now look at for yourself. Click Here.

This is terrible! Just by advertising in Irving and Dallas you should have ten times this! And Eddie is informing us that this is a Global Company! Bullshit. I guess you can get another idea when you are running an online business and on your Twitter site; you are Following almost twice as many that are Following you. And only 800 for a business, I live in a town of 5,500 people and some of their businesses have over 1000 followers. This is pathetic! I haven’t been on Twitter for 3 months and I have more following me, than I follow. This guy could feed the blind bullshit and convince them that they are eating a chocolate bar--he really could. I have to say that he does have persuasive writing skills.

As you just read in the Forward Looking Statements at the beginning of Part II, you would see that ARTS is projected to make $60 Million worth of online business. Will, ARTS only has an average of 500 unique visitors per month. Each unique visitor for the year would have to purchase $10,000 worth of merchandise to equal $60 Million. That is saying every single person that visits the ARTS website in the year would have to purchase $10,000 worth of merchandise. If you buy this then you are a dreamer. I am sure there will be those that don't believe me when I am saying this is not possible, but Eddie has been working on this rewards program for 2 years and he states he has 1,000 members (which is probably over stated), that is not enough to amount to squat. I would like to see someone question Eddie on his extremely poor website traffic, rated below 1.9 million other sites, horrible. Do you own research but it is clear to me, Eddie is pathological when it comes to being honest.


Reverse Split 50-1 in October 2009

In October 2009 ARTS completed a 50-1 reverse split without releasing a press release. Eddie Vakser stated in an email to an ARTS investor that it only appeared they didn’t inform shareholders. Yeah, right, this guy is the worst!
Here is the email supposedly from Eddie Vakser; copied and pasted from Yahoo Finance Board on 2-8-10:

**Email From Ed Vakser on Yahoo Finance on February 8, 2010 in response to Reverse Split Question:

Eddie Vakser: "Let me just tell you how the R/S happened, and maybe once and for all people would just leave that subject alone."

Eddie Vakser: "First of all, everything that I’m about to say is public knowledge. So I’m not disclosing anything new. Anyone who knows how SEC and FINRA authorize and approve things, will agree that Artfest followed proper protocol and procedure. We first filed the request with FINRA, who responded that we will get an answer within 10 to 15 days. FINRA does not want manipulation, so THEY decide When you will start trading after the reverse.”
**(Sounds a lot like the poster teardrops99 on I-Hub, who suddenly deleted every post.)

Eddie Vakser: “Here is how it works. FINRA approved Artfest by issuing a new Cussip Number. Then we had to wait 10 more days for FINRA to assign a new ticker symbol. Artfest could not disclose any information until FINRA gave us a date when the new symbol will be up to begin trading. FINRA gives the company 48 hours PRIOR to posting, so that Artfest could make proper announcement to the public. So, we prepared a press release to come out the day BEFORE the symbol change. However, on that Wednesday, Artfest received an approval from FINRA, and ARTS as a new symbol, with acknowledgement that the trading will start the next day. However, BEFORE we could post our press release, that was still being approved by our attorneys, FINRA had posted the new symbol and approval on their site. Artfest was not alerted that the posting would occur BEFORE the symbol change. So, it looked like we posted PR a day late, when in fact we were scheduled to give proper 24hour notice.”

This doesn’t even make sense. Eddie you are studdering while you write here bud. First you said you prepared…that is past tense; then you say you were scheduled to release but you couldn’t post because your attorney’s didn’t approve it yet. So in other words, investors were NOT warned in time, this is exactly what it sounds like to me? If it looks like you posted a day late--you posted a date late scumbag. How long does it take for your attorney(s) to read a paragraph and grant approval? Investors are pissed off Eddie, because you could have had the courtesy of informing you were going to apply for a reverse split after the BOARD APPROVED IT. You are acting like we are accusing you of breaking the law, (which you actually may have) but investors are ticked due to the lack of factual communication. If this was something positive like; if the board approved a stock buyback or a forward split, I bet you would of made dang sure that a PR would have been released immediately.

Ed Vakser goes on to say: “With all the legal and filings that takes place, you can’t just “sneak” a reverse. As far as the blogs and the boards, a lot of the people who ARE trading, simply do not know the SEC rules and how the trading and transaction occur. Also, we had several instances of people who even admit to first bash the stock and the company, and then buy cheap and sell at the run. **Do you see how much this guy is focusing on the stock price? Some still call us “pinks”, when in fact we are OTCBB and have always been fully reporting. We are a growing company, so we are acquiring assets, companies and talent to help Artfest grow into a global company. We are using everything at our disposal to grow this company, while being in full compliance with SEC. Shareholder value does not mean that you get profit on a quick sale or flip. But rather, what is the company worth at the end of the day, and what are the assets and revenues. We are here for a long term and have a plan. If you are ever in Dallas area, please come by and see for yourself.”

***EDDIE, THIS IS THE YEAR IN WHICH YOU WILL FIND OUT IF YOU ARE GOING FOR BROKE OR ON THE RIGHT PATH. IF BY SOME CHANCE YOU ACTUALLY ARE ABLE TO PAY YOUR DEBTS BACK FOR ONCE THEN I WILL PERSONALLY BE YOUR SLAVE AND KISS YOU’RE A$. You are running out of chances in the investment world; having to beg individual “Angel” investors for money and not making the payments on the contracts you sign…that is BAD business, it’s time for profits, not just revenues, but PROFITS. You are digging a hole that is almost over your head Eddie. You cannot continue to issue shares just as our Government prints money…businesses are not successful when managed this way; in the long run you end up hurting everyone including yourself, even though you are the one that will most likely end up with money. But with the Internet it won’t take but a week until your name will forever be tarnished. So yes you may end up with the money, but if ARTS fails as it is obvious most investors feel this way, you think you are bashed now as a conman, just wait. I hope you aren’t pocketing any of that loan ARTS received.


Dilution

ARTS investors have experienced Massive Dilution through the acquisitions that Arfest International has made since 2008, offering 793,926,561 shares to a variety private lenders, that charged outrageous interest rates, to Eddie Vakser, and to other employees (undefined).Then you pull just an absolute “Dirty” play that was approved by the “Artful” board ---a reverse split without notifying the 2,100 shareholders of ARTS that the board had approved the split (which you should have done), you can say “it ---they say they did though.

This is the kind of press release you should have made; like this company TranSwitch did. Is there a law to say that it is up for board vote? I believe that Eddie just wanted to sell, sell, sell.

These are the main reasons why ARTS is under .01 cent right now. If ARTS is to make any other major acquisitions it would most likely be with stock shares because they do not have adequate cash reserves. Actually I think that any other acquisition is out of the question.

The latest 3rd Quarter 10 Q states that they are issuing $1.2 Million worth of shares to pay for their salaries. Well, that’s over 100 million shares down the drain. I wonder just how many of those shares are going to Eddie?

Anyone want to place bets on how many shares will be outstanding next quarter. It was 65 Million as recently stated in a press release. The rate they are going without making another acquisition is well over 1 Billion…way over! This stock will Never be worth a penny again; I really don’t think it will. Eddie should write a book: "How to ruin a company in two years" by Ed Vakser.

What is it going to take to increase the stock price?

It is simple really. It is going to take PROOF.
Proof that ARTS actually cares for it’s shareholders. *This will be the day!
Poof that if there is another reverse split that it will be made public at least one month in advance.
Proof that they will keep the public up to date on the Outstanding Shares.
Proof of this $60,000,000 in revenues that Ed Vakser is blabbing about.
Proof that Mr. Vakser can manage a company without robbing his shareholders. ROTFLMAO!
Proof that there will be an abrupt end to the behavioral pattern of issuing insanely amounts of shares to private lenders. These shares will eventually stall the growth of this company, soon there will be over 1 Billion Outstanding Shares; enough is enough. There are more shares being added to the float every day.

Right now ARTS is making up shares and handing them out like candy at a parade. I am not sure what the specified restrictions have been placed upon these shares, but I am sure that many are being executed right now…hopefully the restrictions are price based rather than time based, but right now the rate they are issuing shares is comparable to how our government is spending money. I am not even going to go into the preferred shares they are giving out, I don’t even want to know the insane divs they have to pay on the prefs.

If I was a private lender and they offered me shares; from the pattern of leadership in this company I think I would stick with my interest rate and charge late charges. Heck if I wanted the stock that much I would buy my own shares at this price. But of course there is always a risk that ARTS will never pay me back.

The bottom line is whoever gives Ed Vakser money is either scamming with him or about to get scammed.

So I guess if ARTS can sucker these private lenders to convert debt to shares, then ARTS can avoid the costly late fees and high interest rates. I just couldn’t believe the interest rates that ARTS agreed to pay some of these lenders, insane! Is it right to convert some of these debts to shares? Only if ARTS makes a profit and the stock price dramatically increases. Either way I honestly don’t believe that Ed Vakser thought about the loyal shareholders invested in ARTS; I believe he thinks his shareholders are simpleminded and foolish and are their for his use of continuing his manipulative cunning style of managing ARTS. Eddie Vakser would dispose of you like a dirty diaper.




Deception

You know after all the press releases that ARTS does, wonder why the 3rd Quarter 10Q wasn’t released in its entirety on Yahoo Finance? They released the forward looking statements and the positives. They don’t want you to see everything, it’s as simple as that and I believe this 100%. It may have been on their site, late, but at the time no one could find it. They want to sell the shares at the highest possible price and anyone who is half way knowledgeable about reading a 10Q can tell the stock is headed South, Far South. They are hiding the facts. When a company is hiding facts from shareholders it is time to get out! This is a sign that they have absolutely NO Respect or Concern whatsoever for shareholders, they are attempting to save their own ass.

There was a good sign in the 3rd Quarter 10 Q: Under Legal Proceedings it says: “There were no legal proceedings during the nine months ended September 30, 2009.”



Crime Watcher
Find out a complete background for a CEO or anyone in the United States. Find out anything about anyone. Very Reasonable and Affordable Price Options! Check it out.
Click Here!





Scam or Not?

A lot of people have been asking if this is a Scam? It appears that ARTS intentionally dissimulates facts that could have a negative impact on the stock price. In my opinion you have to state the facts if you are operating a public business. So if you only inform your shareholders of the news that sounds positive; then YES this is a SCAM and is being run by a dubious board and a flat out thief for a CEO that treats his shareholders like lab rats. If you read just the Press Releases from ARTS you would beleive they are a DOW top 30 company. .There is never anything negative informed in their press releases. They are doing everything that they can do to keep people from selling and continue buying.



MLM or not?

Does Ed Vakser have a good heart? I don’t know the guy personally, I just know what he has done for his own benefit and my conclusion is that he is a Greedy Son of ______ who has this vision of ruling the world by way of MLM and persuading anyone and everyone he can lure in to give him money. (Including a 70 year old women and he didn’t pay her back so she was forced to litigate.). He is flat out emulating IGI’s MLM and I’m afraid ARTS is going to end up like IGI, Bankrupt. But don’t worry about Eddie, he will have plenty stashed away and he will just come back and do it again and again.

Is this an MLM? Well look at the “Rewards Program” and judge for yourself.

My opinion of MLM’s? Don’t get involved unless you know you are at the top of the food chain (which would be bottom in MLM) or else you will be Eddies dinner. They are the work of the devil in my opinion because eventually they dry up and the links are broke---in ARTS case the members chain would collapse and this could drop a stock quicker than quick! I don't believe this rewards program will work. Eddie has been attempting to recruit since 2008 and recall looking at ARTS website traffic; basically nonexistent! Not Good.

It clearly appears that Ed Vakser is cloning this program from his shady days at International Galleries, Inc (IGI). Here is an excerpt from the thief himself Paul Myers at IGI when IGI’s President, Stan Leitner, and Master Member Paul Myer are asked to explain why the company has been so successful so quickly, they point to:
(1) The exclusive, state-of-the-ART IGI product and
(2) The unique IGI Member Rewards Plan that pays cash daily.


“This is the first time Member Rewards have been provided in this way, as both an incentive and a compensation,” Paul Myer comments, “and people are excited about a program where the Member Rewards are paid in cash!”

Does this sound familiar ARTS shareholders? I believe we have read this one before.


I personally think Eddie is out of his mind after being involved with the crooks over at International Galleries, Inc. Many say that Eddie was one of them, but he was never prosecuted after the MLM scheme that was very similar to ARTS recent rewards program…VERY SIMILAR. This scheme at IGI left 30,000 people wondering where their life savings went. If you do your DD and research some Dallas newspapers you can read all about it. Eddie is basically running this company the identical way that IGI was run; now that is scary.


I’d like to see ARTS succeed due to my personal investment, but I really desire the CEO to be honest and just tell it how it REALLY is! I really don’t want my fortune to be made by someone else’s misfortune by not getting in soon enough. I wouldn’t be able to sleep if I conducted myself in a similar manner as Fast Eddie.

You do not grow a company by depending on the sales of “Members” to do the work. You have to do the work and not just promote how good things will be; Eddie.



The Dean should Promote ARTS Again in June
One thing you investors in ARTS should be able to count on is another promotion by “The Dean” in June if ARTS still exists. The Deans restricted shares near the unrestricted date and the dean will want the highest possible price he can get. I know this from observing The Dean’s past behavior that he will want to dump his 750,000 shares at the highest possible price. Right now they aren't worth much of anything--just a little over $5,000. Also…last week he promoted IVOB again and it was an IVY LEAGUE pick; but newcomers to the dean wouldn’t have known that IVOB was an old pick and he is getting ready to unload the shares that become unrestricted. He will probably do the same with ARTS.

This may be a time to dump your shares if you have become a bag holder; who knows, maybe the price will increase in the meantime. If you look at some long term charts there have been some runs that were quickly followed by dips. But with all the employees trying to get rid of their shares in lieu of a paycheck, I have some doubts.



ART Illusions

The point of this blog is that everything isn’t as beautiful as it appears to be in the Artful Crafted Press Releases---I started out by delineating a somewhat positive image for Artfest International by going over some of their forward looking press releases throughout the past year that gave investors that warm, fuzzy and comfortable feeling that they have truly found a hidden gem of a company …but then I began getting into the things that ARTS didn’t make public, the stuff you have to dig for, the fine print that often goes unnoticed and once you discover the whole story you come closer to the truth. Revenues looked good but for a penny company in this weak credited economy, you need a profit to pay your bills. ARTS needs to pay them without using stock shares and begging for loans to whoever will give you the time of day.


Does Artfest International have any Potential?

Artfest International has a full plate right now. They are in the process of making 30 minute episodes of Rhupert the Ostrich, they are trying to sell Natures Sleep Visco Memory Foam Mattresses, they are trying to get their Members Rewards Program going, they are still trying to get their ARTS TV channel (Arts Channel) going…which I don’t think will ever be successful unless they can get it on a channel that can be easily accessed, and they are trying to sign with more Professional and College Teams with CSD.

I like CSD subsidiary as I think there could be some potential here. As for the potential of everything else; I really don’t know, I guess time will tell. As soon as the next 10Q is released I will be all over it.

It appears that they have no direction. They jump from one failed project to another, just the case as former Vakser companies.

If they are lucky enough to discover something that works, then I think they should focus on that.

Short Term Outlook for ARTS

What is the short term outlook? Not Good! Too many Free Shares to Sell. In the 4th Quarter; which is right now, there are to be $1.2 Million worth of restricted shares that become free to sell to their employees. You couldn’t find this information on Yahoo Finance, for good reason---ARTS just wants the public to see the forward looking aspects of the company so they can pay their employees. Yes, Eddie can’t even pay his employees…this equates to 1 Billion Shares just for salaries past due. How is he going to pay for the rent increase, the new CFO, new advisor Vandeweghe, acquisitions, the electric bill, and so forth?



Long Term Outlook

Long Term? I don’t think there will be one. I think this was a money scheme from the beginning and the Vakser’s know this and the board knows this.This of course is making inferences from the past. I give Artfest International a 50/50 chance of making through 2010. I believe when they hit bottom, they will hit hard and fast and they will go quickly. There may come a time that good ole Eddie will be run out of Dallas, from what I’ve heard there were/are some very upset private investors that definitely played part in the decisions to continue to issue shares for salary debt. Eventually the word will get around Dallas and if ARTS fails you can bet there will be many investors that will do their part on tarnishing Eddie Vakser's name.


After all of my research I get the feeling that Eddie Vakser is attempting to SOME things right…he is surrounding himself with a couple of reputable people…at least on paper it looks that way. But just as the saying goes “you can take a person out of the trailer park, but you can’t take the trailer park out of the person” and this is my personal opinion of Ed Vakser.



Other Red Flags:

It frightens me that this company has two siblings on the board; Ed and Angie that have been involved with MLM companies that have went bankrupt and the two of them always came out wealthy.

The company has a history of having NO CASH! There bank account is at zero.

Eddie Vakser jumps from one company to another; after he gets everything he can from one he moves on to the next opportunity. The best thing that could occur in my opinion is that the Board suggest that EV along with his sister resign and move on. I don’t believe ARTS will grow with E.V. at the helm. E.V. is a promoter, not a CEO.

They are vesting an indefinite amount of shares to themselves. It’s like they have found a blank checkbook full of checks and just started writing check after check after….this is definitely a desperate move that should raise a red flag.



Links that do not work: http://www.artchannel.info/ --probably because they don’t want you to know. http://www.art-tv.net/ ,

If you go back and look at two characteristics of every single MLM program conjured up, you would see over-inflated press releases and over exaggerated potential earnings that never could be possible. Take a look at the press releases from ARTS; in short all they are is advertisements that want to get you, the potential investor excited about the Enormous potential that their company has. They want to get you to open that check book and dish out the cash. I have not read a negative press release yet; and this means they are not being honest! An honest company sends out details of what is going on regardless if positive or negative. If Eddie was running a Biopharmaceutical he would say every drug they are developing is going to be approved, even if the FDA says not. This is a Big Time Red Flag.

I really don’t think ARTS would be in existence today if it were not for the acquisition of CSD. The Art Channel was not working, is not working now and NEVER will Eddie. What concerns me is that they will misuse the revenues that CSD brings in by trying to ride a dead horse with this television channel. They cannot afford this. Don’t mismanage the revenues with CSD, Eddie, ya hear me. If this is going to work you cannot use CSD revenues to fund your “Out of this World Crazy Ideas”. You can eventually but not now. Use CSD to get your business so you can at least make payments on your debts without diluting the holy s_ _ t out of OUR shares.

How are they funding Rhupert and Memory Foam Infomercial? I don’t know. I wish they would throw everything out right now and focus on CSD, that is what can have the potential to raise stock price. I really don’t know what to think about the Rhupert deal. I think Eddie dreams too big though and will try to do everything at once and that’s how it will END.

The way they finance; just for example: On January 31, 2008, the Company signed a Promissory Note payable to the TBF Charitable Trust Foundation for $50,000 due on July 31, 2008. The loan accrues an interest at 1.5% per month, or 18% per annum, and with interest and penalties the total due pursuant to the Note was $190,000. A $50,000 loan almost 4 times the amount loaned. This occurred in less than 2 years! Just think about the recent $900,000.00 loan and the penalty fees they will be paying. How much do you think Eddie will steal from this?

The last but not least Red Flag: As Dr. Phil says: “You can usually tell how a person will behave in the future by observing their past behavior”. I hope this doesn’t mean another bankrupt company! I think Eddie needs to spend some time in a Federal Penitentiary because he has been screwing everyone and now it's about time he gets screwed; literally.



Products

All successful companies offer great products or services. I have been through the Artfest International website numerous times and I just don’t see a product that will sell like hotcakes. This is ALWAYS the case of an MLM; yes nowadays they do have sell something besides memberships---as laws have forced them, but they don’t have anything that you can look at and say “Wow, this is a great product with excellent potential”. I just don’t see it. There are a couple of Michael Jordan framed posters I like, but they are very expensive and I have two of them---if I could get 50% of what their ask price is I would sell in a heartbeat. I also struggle with the fact that the signatures are authentic--due to what I now know about the Vakser’s history, but I assume that they are due to the fact that CSD has been a reputable company.

Concluding

Artfest International is struggling big time right now. Even though there is that diminutive probability that Ed Vakser is attempting to run a legitimate company for once, I don’t see the Art Channel aspect of ARTS working at all…throw this out the window.

This is Eddie Vakser’s third time he has either owned or been part of developing a television channel. When Eddie was CEO of Ecine he purchased America’s Choice (2000)--it was booted off the Dish Network within two months because all he ran was infomercials, Eddie created the Performance Lifestyle Channel (2005) and the Art Channel (2010). I don’t know if the Performance Lifestyle Channel is still on the air anywhere or not; anyone know? I have been visiting their website at TNT Media Productions and it says “To better serve our customers we are currently updating our website. Please check back soon for updates“. Now I have designed many websites before and I didn’t have to shut my whole site down to construct it. This is another one of Eddies companies.

I like the Charity Sports Distribution part of ARTS. I think if this is managed efficiently it can make some money; eventually. I just hope Eddie doesn’t do anything to screw it up, lol. In my opinion ARTS was basically a shell company doing a reverse merger when they acquired CSD. CSD may save their ass, if the stock ever goes to a nickel this year I will be more than happy.

The question is; can ARTS survive long enough to actually become profitable and pay its bills. Even if ARTS does become profitable in my opinion I believe it will be too late for long term investors as if you were in it for the long term your shares already would be virtually worthless due to reverse split, dilution and declining stock price.

Well, it is now known that ARTS is depending on their stock price to pay for their salaries. They stated in their latest 10Q that they will issue $1.2 Million worth of shares to themselves; do the math people, that is over 100 million shares at .01 cent a share and now the stock is .0067 and tail spinning. The stock is crashing because of this. How do they plan on paying salaries for the rest of this year? With my money? I am not giving my money to a lying, cheating, deceptive thief to pay for his own salary instead of putting it to use to make money for the company. We need profits to pay the bills, forget about acquisitions.

Eddie probably spends more money on press releases than he does on running the business..

All I can say is that CEO Eddie Vakser is confident. Are You???


Investor Relations: Investor Relations: Call 407-389-5900
They don’t have an Investor Relations email address but you can email Eddy himself as he has nothing better to do than to try to pump everyone up to purchasing ARTS, so he probably will respond.
To view the latest filings on ARTS go here:
*I strongly encourage you to check this often, as you should know by now that CEO Vakser and family is always scamming and scheming to benefit himself by creating ways to steal stock. To learn more on Ed Vakser read this article “Is Ed Vakser a Crook?”

Direct to Latest 10Q:


Questions to ask ARTS:

ALL investors should call and ask these questions? And any other questions or concerns.

1. How many shares have been issued to employees for pay since September 2009?
2. What is the status of the infomercial on Nature’s Sleep Foam Mattresses? How is it being funded?
3. What is the status of Rhupert the Ostrich series? Has anyone been interested in picking this up?
4. Why wasn’t the 3Quarter 10Q released in it’s entirety to investors on your press release?
5. Why don’t you have an Investors Relations Email Address?
6. How do you plan on paying salaries for the rest of 2010? With shares?
7. How do you plan on paying debts for 2010? With shares. OR do you even plan on paying debts?
8. Why don’t you have an investors page that displays the current float and outstanding shares? How many Outstanding Shares right now as of today? (There will be a Billion real soon, I guarantee this, Ed knows no other way to run a business!)
9. Is Vladimir Vakser on the payroll or has he received shares for a service or for free?
10. How do you sleep at night? (You freaking thieves)


I am not attempting to influence anyone to buy or sell shares of ARTS, I just want the truth to come out, that’s all. Investors will have to patiently wait for the next 10q due out late March 2010 and hope to you see profits, not revenues. Two things to focus on is profits and outstanding shares. PROFITS are the only catalyst that will allow ARTS to continue operating.*Note: I do own shares of ARTS and pray it goes up so I can GET OUT.

If something sounds to good to be true…it probably is!


Good Luck, invest at your own risk.


P.S. If Eddie Vakser can convince his dubious board to do a reverse split without notifying shareholders, how many shares do you think he can persuade them to give to himself in Lieu of Salaries not paid? Click here to check out info on Eddie Vakser.

GovRec
Search for ALL Public Records on Sex Offenders in your neighborhood, search Civil Records, search Businesses, CEO’s and Bankruptcies. Look up old Marriage Records, look up Death Records, and get UNLIMITED Public Record Checks. Find Anyone, Anywhere! Get their current phone number and phone number history, current and previous addresses. Use what Private Investigators use.
Get Started Now!

Copybox
Are you LAZY? If you are then this may be for you. All you have to know is how to Copy and Paste which will be described to you step by step. This is a powerful, profitable system that will inform you step by step. If you need some extra $$ to pay the bills then give this a try. A great system for those that are disabled and need a secondary income or for that matter anyone desiring a second income. Truly no web experience needed as all you need to do is follow the directions step by step. Just check this out.
Click Here!



MovieCap
Download entire Movies to your computer. 100% Legal. No worry about viruses or spy ware. Works with small bandwidth, so anyone can do this. This is not a file sharing P2p deal here; this is Direct downloads to your computer. Create your DVD collection on your computer.
Click Here!


RT$: You Can’t Judge a Book by its Cover Part I

ART$: You Can’t Judge a Book by its Cover Part II

Monday, February 8, 2010

Is GNVC going to take off?

Follow me on Twitter

GenVec, Inc (GNVC) a biopharm with an experienced management team that is currently in Phase III trials with it's potential Blockbuster drug TNFerade for inoperable pancreas cancer -- (Pancreatic Cancer). GNVC believes strongly that TNFerade will soon be the practical treatment for Pancreas Cancer.

GenVec's stock (GNVC) has gone nuts since the news release of the awaiting184th event along with buying pressure from a Cancer Conference in Florida relative to their lead drug candidate for MULTIPLE cancers, but focusing on Esophageal Cancer at the Symposium. The stock price has gone from $1.00 to $3.34 in less than a month; actually the past two weeks! Everyone saw what happened with Dendreon (DNDN) when their Phase III trial was a success; its stock went from $4.00 to over $22.00 in a week! That is over 5 times your money. If you had invested $4,000 at $4.00 a share you could have pocketed a cool $18,000 in a week. Why am I saying this? Because GNVC displays similar attributes. IF TNFerade Phase III trials are successful you can count on GNVC absolutely flying just as DNDN did. There has been a buzz about GenVec for the past six months and it was just a matter of time before the price took off as it did last week--people are so zealous they can hardly wait for the results. I boldy believe that this may only the beginning if TNFerade's Phase III trial is successful. Results from phase II started the buzz. Investors along with Mutual Funds and Institutions have this pivotal Phase III on their radars. It may be worth it to just purchase a100 shares after observing the aftershock of DNDN's stock. GNVC has a pipeline that is quite impressive as you may read later on here which eases the "downside" and this strong pipeline acts as a reinforcement and leads to the justification on taking a shot at this one.

I wouldn't be surprised if GNVC attempted to raise some funds. Why? Because now would be the absolute perfect time while the stock has been nothing but going up for 3 weeks and they need funds to continue with the Variety of studies they are in the process of which you will see below...great pipeline and TNFerade may be successful in Multiple forms of cancers. The potential is there for a Mega Blockbuster for the various treatments that TNFerade could provide. Just pancreas cancer would be a Blockbuster....Blockbuster is defined in the stock world having a $Billion potential.

*****UPDATE: GNVC announced that it is going to raise capitol of $28 million at $2.00 per share; exercisable at $2.75. http://finance.yahoo.com/news/GenVec-Announces-Registered-prnews-4197154088.html?x=0&.v=1


Insiders Not Selling GNVC

You can often get a feeling about a stocks future success by observing insider selling. GNVC insiders have not been selling so far; so in my opinion they are just as excited as the investors! In 2010 there have been no reported selling.





SEE FULL CHART BELOW ON BOTTOM OF PAGE:

It is estimated that about 40,000 new cases of Pancreatic Cancer will be diagnosed in 2010. The overall survival rate after 5 years is only about 5%. So 95% of pancreas cancer patients will die within 5 years. Do you see why GNVC is getting all the attention right now? The current treatments for Pancreatic Cancer are not working.


Download entire Movies to your computer.
100% Legal. No worry about viruses or spy ware. Works with small bandwidth, so anyone can do this. This is not a file sharing P2p deal here; this is Direct downloads to your computer. Create your DVD collection on your computer.
Click Here!


Pancreas Cancer is the fourth leading cause of cancer related deaths. Pancreatic Cancer accounts for about 2% of ALL the costs of caring for cancer patients. It is estimated that well over $1 Billion will be spent in 2010.

Today January 26, 2010 GNVC finally had a down day. The stock closed at $2.47 down .19 cents or 7.14% today. The low of the month was $1.23 and that was the first trading day of 2010, January 4th. The high so far this month is $3.34, yesterday January 25, 10. It will be very interesting watching this stock for the next month as more and more take a position; just to be in it to have a chance of another DNDN.

t is expected that GNVC will have statistics regarding this pivoting Phase III trial of TNFerade next month; February 2010. Stay tuned! GNVC has a pretty alluring pipeline also; so it's not a "one trick pony" so to speak. Read my personal notes below to learn a LOT more about the HUGE potential of GNVC. The sleeping Giant has awakened!
**Plus GNVC has just signed an agreement with Novartis.

Slow Computer? Read this it is a fix. Never buy a new computer because it is running slow; there is no reason why it cannot run the way it did from the very First Day you opened it from the Box!
Click Here!



Here is a copy of my personal "diary" of my notes from GNVC, if interested.
GNVC--GenVec, Inc. **Potential to easily double from October 5, 2009! If TNFerade is shows a good survival rate. EPS= -.266 cents. Market Cap: $79 Million. Market Cap as of October 13, 2009 is $104 Million. Outstanding Shares=106.2 Million shares. Average Volume is 1.5 Million Shares traded each day. Institutional Ownership: 12%. Short Interest: 9%.

Results expected in 1Q 2010...so stock price will rise at first of year. They have a HUGE Pipeline and excellent potential.

Stock Price as of June 1st, 2009 is ($0.72) Stock Price as of October 6th, 2009 is $.79 cents. Stock Price as of October 13, 2009 is $.98 cents.
I purchased this stock at .75 cents, then sold at $1.00

From Yahoo Finance:
GenVec, Inc., a clinical stage biopharmaceutical company, develops gene-based therapeutic drugs and vaccines in the United States. Its lead therapeutic product candidate, TNFerade biologic, is under Phase III trial for first-line treatment of inoperable, locally advanced pancreatic cancer. The company is also evaluating TNFerade for the treatment of various cancers, including esophageal cancer, rectal cancer, and head and neck cancer.

GenVec is also developing TherAtoh, a preclinical program involving the delivery of the human atonal gene for the production of therapeutic proteins by cells in the inner ear. Further, GenVec uses its proprietary adenovector technology to develop vaccines for infectious diseases, including HIV, malaria, foot-and-mouth disease, respiratory syncytial virus, and HSV-2. It has strategic alliances and research contracts with the U.S. department of homeland security, the U.S. department of agriculture, PATH’S malaria vaccine initiative, the U.S. naval medical research center, and the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The company was founded in 1992 and is based in Gaithersburg, Maryland.

Sources for information for information below.
This is a great article that describes a lot of what you need to know about GNVC.

Article regarding head and neck cancer.

Below: This explains the PACT trial. PACT study) with TNFerade[TM] in patients with locally advanced pancreatic cancer: On January 3, 2008 these 2 changes were agreed upon with the FDA and GenVec


* (1) Measure overall survival as the primary efficacy endpoint, rather than 12-month survival. No increase in study size will be required, and a benefit in overall survival can be considered as a basis for full regulatory approval of TNFerade for this indication;

* (2) Conduct two additional interim analyses of overall survival following one-third (92) and two-thirds (184) of the total events (deaths) for the study, with the potential to stop the trial if there is clear evidence of the drug's efficacy. The two interim analyses will be performed with minimal statistical penalties of 0.001
There is a total of 330 patients with 220 of them to receive TNFerade plus Chemo and Radiation and the other 110 to receive only the standard care of Chemotherapy plus Radiation.

GenVec, Inc announced that overall survival data in locally advanced pancreatic cancer patients treated with TNFerade in GenVec's ongoing Phase 3 Pancreatic Cancer Clinical Trial with TNFerade (PACT) were presented at ASCO. **Comment 10-29-09: I believe this is after 92 Deaths; so there would be 238 living. The analysis concluded that TNFerade appeared to be safe and well-tolerated, indicating a 25% reduction in the risk of death in the TNFerade plus standard-of-care (SOC) arm compared to the patients receiving SOC alone. In the SOC patients, 75% of the patients died within approximately 11.8 months. However, in the TNFerade plus SOC group, 75% of the patients did not die until approximately 19.4 months. GenVec's PACT trial is a multi-center, randomized, active, and controlled study of 330 patients designed to evaluate the safety and efficacy of TNFerade plus standard of care versus standard of care alone in patients with locally advanced pancreatic cancer. The next interim analysis is expected to occur after two-thirds of the events (or 184 deaths) have occurred in the trial. Results are expected to be announced in early 2010.

Aug. 28, 2009 just read this on post on ARNA board that this stock has potential in 2010. Stock Price on August 28, 2009 is $.7556 which was down a penny today or 1.83%. Stock Price on September 15, 2009 is $.84 cents up .05 cents today. This company is developing a drug called TNFerade for Pancreatic Cancer and they say it could have other benefits in treating Rectal Cancer. They also have a FMD vaccine agreement with the FDA. ******Potential Doubler in one year from now…meaning within the next year, one year from today August 28, 2009 I believe this stock will double from .75 cents to $1.50, sometime within this year. Update: September 15, 2009---Evidently the news is supposed to come out soon, so this stock will move one way or the other here shortly…need to research more, all I know is that Pancreatic Cancer is in need of new drugs, unfortunately the ones that I am studying all deal with survival rates, so in order to get a drug out they have to complete trials in which the majority of peopled die and I don’t think that is the correct incentive for a drug company; I mean they are only focusing on creating drugs that will mildly increase survival by a six months or so.
**Update: January 24, 2010: GNVC is over $3.00

The below information is from
http://www.istockanalyst.com/article/viewarticle/articleid/3468585

Pancreatic cancer is the lead indication for TNFerade™. They are conducting a 330-patient randomized, controlled Phase III clinical trial (the PACT study) designed to assess the safety and clinical benefit of using TNFerade™ in combination with standard of care treatment in patients with locally advanced pancreatic cancer. They are expected to be completed by Q1 2010.


Positive Results from Phase II Trials

29 patients were treated at University of California Irvine Comprehensive Digestive Disease Center between 1/2003 and 11/2008; 20 patients with TNF + SOC and 9 patients with SOC. In the TNF + SOC treated group mean age was 64.8 (range 50-80); 15 male; 12 tumors were Stage II, 8 Stage III. In the SOC treated group mean age was 65.9 (range 52-84); 5 male; 6 tumors were Stage II, 3 Stage III. Kaplan-Meier survival analysis showed the overall median survival was 14.7 months in the TNF + SOC treated group and 11.1 months in the SOC treated group. Conclusions In patients treated at a single institution in two similar trial settings, TNF + SOC resulted in a median survival of 14.7 months vs. 11.1 months for patients receiving only SOC. These results are encouraging and are consistent with results across both multi center trials that show a trend towards improvement in survival following the addition of TNFerade Biologic to SOC.

Recent developpment. The analysis concluded that TNFerade appeared to be safe and well-tolerated. The analysis also indicated a 25% reduction in the risk of death in the TNFerade plus standard-of-care (SOC) arm compared to the patients receiving SOC alone (Hazard Ratio = 0.75; 95% Confidence Interval [0.494 - 1.15]).

Dr. Mark Thornton, GenVec's Senior Vice President of Product Development commented on the poster, noting, "In the SOC patients, 75% of the patients died within approximately 11.8 months. However, in the TNFerade plus SOC group, 75% of the patients did not die until approximately 19.4 months. Although the data still need time and events to reach maturity, we are encouraged by the survival trend being observed at this point in the trial."

TherAtoh Atonal therapy is a product concept to restore hearing or balance function through the regeneration of critical cells of the inner ear. Hearing and balance require specialized cells of the inner ear called sensory hair cells. During embryonic development a gene termed atonal (ATOH) induces the generation of these cells. GenVec has shown preclinically that the production of the ATOH protein results in the formation of new inner ear sensory hair cells, and the restoration of hearing and balance function.

There are currently no effective treatments available for patients who have lost all balance function, and hearing loss remains a major unmet medical problem.

The market potential for this product is truly mammoth, as the cost of medical care for patients with balance disorders has been estimated to exceed $1 billion per year.

Vaccines

HIV Vaccine

In collaboration with the Vaccine Research Center/National Institute of Allergy and Infectious Diseases/National Institutes of Health, GenVec is developing a vaccine candidate to protect against the three most common types of HIV-1 virus found around the world, clades A, B and C. The vaccine candidate utilizes GenVec's proprietary adenovector delivery technology and 293-ORF6 production cell line and is designed to generate a broad spectrum of immune responses including neutralizing antibodies and cytolytic T cell immunity characteristic of the most effective vaccines.

The Vaccine Research Center is managing the clinical development of this program. The vaccine candidate (VRC-HIVADV014-00VP) is being evaluated alone and in combination with a plasmid DNA vaccine prime. In October 2005, the VRC announced the initiation of Phase II testing for this vaccine candidate. In addition, six Phase I trials have completed enrollment with more than 150 healthy participants having received the adenovector vaccine candidate.

Vaccine Research Funding Worth $50M

In 2004, GenVec announced an expanded collaboration to include the development of a second-generation vaccine candidate. This program is being funded through a subcontract managed and administered by SAIC-Frederick, Inc. worth up to $50 million.

Penny Alerts you cannot Survive without! Check this website out, do some DD.
Roys Best Penny Alerts. Get in before the Crowds



Malaria Vaccine

In collaboration with the Naval Medical Research Center (NMRC), and with additional research support from the Malaria Vaccine Initiative (MVI), GenVec is developing multi-antigen vaccine candidates, produced using GenVec's proprietary 293-ORF6 cell line, designed to attack both the blood and liver stages of malaria, a complex parasitic disease. The intention is to generate a broad spectrum of immune responses including neutralizing antibodies and cytolytic T cell immunity, characteristic of the most effective vaccines. This approach toward eliciting a broad spectrum immune response and attacking multiple stages of the life cycle has shown promise in pre-clinical animal models.

In January 2007, the NMRC initiated Phase I testing of a vaccine candidate jointly developed with GenVec at its clinical trials center. The first phase of this study is designed to evaluate the safety and immunogenicity of two doses of the vaccine candidate in healthy volunteers. After safety evaluation and confirmation of the optimal dose, the second (challenge) phase of the study will evaluate the protective effects of the vaccine following exposure to malaria. The ability to safety challenge human volunteers provides a unique opportunity for assessing the efficacy of candidate vaccines prior to the initiation of field trials.

How a College Dropout Turned $1,000 into $1 Million. Trade Alerts that make you money; Guaranteed! Try it; if you don't like it get your money back, but I have a strong feeling that it could pay for itself within the first couple of trades..even for beginners!
How a College Dropout Turned $1,000 into $1 Million. This can be accomplished with less than 100 Trades. Get his Alerts Now! A Must have for ALL Penny Investors…get on the inside


Foot and Mouth Disease

In collaboration with the U.S. Department of Homeland Security and the U.S. Department of Agriculture (USDA)-Agricultural Research Service (ARS), GenVec is developing candidate vaccines and anti-viral agents to prevent the spread of FMD. FMD has been identified as a key potential threat to the U.S. economy and the country's food supply, whether infection were to occur as a result of bioterrorism or by accidental exposure to the disease.

In studies with DHS, ARS and GenVec, GenVec's proprietary adenovector system and cell line was utilized to safely produce, for the first time on the U.S. mainland, an effective FMD vaccine. Preliminary testing by DHS scientists has shown that this vaccine candidate effectively prevented clinical disease (symptoms) in cattle when they were challenged with the FMD virus. Results from these challenge studies were reported on November 11, 2005, at the 8th National Meeting and 1st International Meeting of Researchers of the Livestock Sciences by Marvin Grubman, Ph.D., USDA-ARS, Plum Island Animal Disease Center, who conceived and developed this vaccine approach. The DHS Targeted Advanced Development group at Plum Island Animal Disease Center, led by Laszlo Zsak, D.V.M., Ph.D., is also collaborating with ARS and GenVec in the development of the vaccine.

In addition, anti-viral candidates are being developed to prevent the spread of FMD from the time an outbreak occurs until the vaccine has generated a sufficient immune response to protect the animal.

Without a marked vaccine that can be safely manufactured in the U.S., options for responding to an FMD outbreak in the U.S. are more limited. The curtailment of meat and meat products for domestic supply and the stoppage of meat exports would have severe economic consequences. For example, in its January 2003 Final Report as required by the Animal Disease Risk Assessment, Prevention and Control Act of 2001, the USDA's Inter-Agency Working Group notes that the 2001 outbreak of FMD in the United Kingdom resulted in the slaughter of some 4 million animals and a loss to the British economy of between $3.6 and $11.6 billion. The report also notes that U.S. exports of cattle, sheep, hogs, and many of their products varies annually from $6 to $10 billion, that many of these exports would face restrictions during an FMD outbreak, and that if even one area of one state was affected by FMD, trade restrictions would be imposed on the nation as a whole, at least during the initial stage of the outbreak.




Attract Customers to your Web Site in 15 Minutes..If you are having problems with your Blog or Website then this is for you.
Click Here!

Experienced Management & Board of Directors

GenVec truly stands apart from other biotechs simply due to its well-rounded and experienced management team. Paul H. Fischer, Ph.D. has served as President and Chief Executive Officer and as a director of Genvec, Inc. since 1996. Prior to joining GenVec, he was Executive Vice President of Research and Development with Oncologix, Inc. (now Antigenics, Inc.), a biotechnology company. Previous experience included Manager, Cancer Research at Pfizer, Inc., a pharmaceutical company. Dr. Fischer received his B.S. in Biology from the University of Denver, his Ph.D. in Pharmacology from the University of California at San Francisco and performed post-doctoral research in Pharmacology at Yale University School of Medicine and was an associate Professor of Human Oncology at the University of Wisconsin.

Now if the CEO's Pharmacology post-doctral research at one of America's top unversities, Yale, is not enough to instill confidence in you, take a look at the rest of the company's celebrated and accomplished individuals at the helm. For a list of GenVec’s Officers and Directors go here "http://www.reuters.com/finance/stocks/officerProfile?symbol=GNVC.O&officerId=166993"http://www.reuters.com/finance/stocks/officerProfile?symbol=GNVC.O&officerId=166993

Financial Analysis

GenVec ended the second quarter of 2009 with $12.6 million in cash and investments. ( source )

"Based on existing contracts and collaborations, we anticipate revenues for 2009 will be between $15.0 million and $18.0 million. We project our cash burn to be between $8.0 million and $11.0 million for the 12 months ending June 30, 2010," commented Douglas J. Swirsky, GenVec's Senior Vice President and Chief Financial Officer. "In spite of the difficult economic times, GenVec continues to make strides in its therapeutic and vaccine programs. We look forward to sharing additional data from our pivotal trial in locally-advanced pancreatic cancer early next year."
Additionally, GenVec was one of the few companies within the biotech industry to receive the maximum Buy Rating from Reuter's Analyst Recommendation System.



Major Institutional and Mutual Fund Holders

GenVec ranks among the best of any companies we have ever profiled when it comes to attracting institutional and mutual fund investors. This represents a very bullish forward looking guidance, as these high profile investors usual infuse large cash amounts with each trade. Here is a breakdown from Yahoo Finance of the major players which are heavily invested.

Number of Institutions Holding Shares: 36
% of Shares Held by Institutional & Mutual Fund Owners: 13%

Now if you've been around the investments niche for quite some time now, you know that whenever 36 institutions are holding a company, this represents a major bullish signal and a company with a lot of future potential. However, if you're an expert like our Founder, and Lead Investment Analyst, these figures aren't impressive unless you know who exactly these mutual funds and institutions are. Well, lets take a look:

When you are in the company of Vanguard, Barclays, Bank of America Corp., Spartan and Royce Micro, just to name a few, there is no better feeling than being a part of a stable and profitable investment.

Overall Sentiment

Expect prices to rise back to the $1.50 – $2.00 levels as investors become more aware of the deep pipeline being offered by GenVec. *Update: As they have last week!

Surrounded by cash infusions through grants, mutual and institutional investors, multi-purpose products with billion dollar market potential, and an already flowing revenue stream – GenVec is one company you shouldn't pass by.

When analyzing the future guidance of GenVec, all you need to do is remind yourself of the story on Dendreon Corporation, and how the results on TFNerade's Phase III during Q1 2010 will affect the price.

TNFerade Treatments for Pancreatic cancer (Fast Track FDA Designation), possible treatments in head and neck cancer, esophageal cancer, and rectal cancer. Add Vaccines for HIV, Malaria, and Foot and Mouth Disease to that list and one thing is clear – The potential for GenVec is truly astronomical.




#1. How a College Dropout Turned $1,000 into $1 Million. Trade Alerts that make you money; Guaranteed! Try it; if you don't like it get your money back, but I have a strong feeling that it could pay for itself within the first couple of trades..even for beginners!
How a College Dropout Turned $1,000 into $1 Million. This can be accomplished with less than 100 Trades. Get his Alerts Now! A Must have for ALL Penny Investors…get on the inside

#2. Penny Alerts you cannot Survive without!
Roys Best Penny Alerts. Get in before the Crowds

#3. Go with the Flow...Discover the stocks that will fly!
Go with the Flow!

Attract Customers to your Web Site in 15 Minutes..If you are having problems with your Blog or Website then this is for you.
Click Here!

Slow Computer? Read this it is a fix. Never buy a new computer because it is running slow; there is no reason why it cannot run the way it did from the very First Day you opened it from the Box!
Click Here!

To put it bluntly here: There are ample reasons to think about investing in GenVec. The hype has arrived and isn't going away. There may be some dips in the next few weeks that will present some good entry points for those of you who are new to GenVec.

*One last note: Investing in any pharmaceutical can be extremely risky; especially after the price has risen like it has the past few weeks. I believe the downside is not unlimited as with many pharmaceuticals that have only one drug---GNVC has an extensive pipeline that can produce high revenues in the future. Do some DD on GNVC!
GLTYA!!!

Chart of Insiders Not Selling GNVC
Go here to see Full Chart Please and to see Insider Purchases.



Recent Posts:
How to make money from Delcath Systems

ART$: You Can’t Judge a Book by its Cover

Is Kraig Biocraft Labs worth investing in?

Trading Penny Stocks Can Change Your Life.